je.st
news
Pfizer 2Q mixed, maintains 2013 outlook
2013-07-31 03:52:59| Biotech - Topix.net
The drug company earned $14.1 billion, or $1.98 per share. That compares with $3.25 billion, or 43 cents per share, a year earlier.
Tags: mixed
outlook
maintains
pfizer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||